Fax +34 93 260 77 87
Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California
Version of Record online: 29 JUL 2009
Copyright © 2009 UICC
International Journal of Cancer
Volume 126, Issue 3, pages 790–795, 1 February 2010
How to Cite
Duell, E. J., Holly, E. A., Kelsey, K. T. and Bracci, P. M. (2010), Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Int. J. Cancer, 126: 790–795. doi: 10.1002/ijc.24792
- Issue online: 8 DEC 2009
- Version of Record online: 29 JUL 2009
- Accepted manuscript online: 29 JUL 2009 12:00AM EST
- Manuscript Accepted: 10 JUL 2009
- Manuscript Received: 7 JAN 2009
- California Department of Public Health
- National Cancer Institute's Surveillance
- Epidemiology and End Results Program. Grant Number: N01-PC-35136
- Centers for Disease Control and Prevention's National Program of Cancer Registries. Grant Number: #U55/CCR921930-02
- 1Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71–96., , , , , , .
- 2Cancer of the pancreas. In: SchottenfeldD, FraumeniJFJr, eds. Cancer epidemiology and prevention, 3rd ed. New York: Oxford University Press, 2006. 721–62., , .
- 3Environmental determinants of exocrine pancreatic cancer. In: PourPM, ed. Toxicology of the pancreas. Boca Raton: CRC Press, 2006. 395–422., , .
- 4Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. Cancer Res 1986; 46: 2276–81., , .
- 5Protective effect of oestrogen in pancreatic cancer. Lancet 1987; 2( 8565): 977., , , .
- 6Effects of sex steroid hormones on pancreatic cancer in the rat. Int J Pancreatol 1990; 7: 159–65., .
- 7Hormones and pancreatic cancer. Int J Pancreatol 1991; 9: 81–6..
- 8Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989; 44: 833–9., , , , .
- 9Anthropometric and reproductive variables and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer 1992; 52: 24–9., , , .
- 10Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 1993; 4: 505–11., , .
- 11Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women. Am J Epidemiol 2005; 161: 741–7., .
- 12Menstrual and reproductive factors and pancreatic cancer risk in women. Int J Cancer 1995; 62: 11–4., , , .
- 13Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer 2003; 105: 408–12., , , , , .
- 14A case-control study of pancreatic carcinoma. J Cancer Res Clin Oncol 1982; 103: 93–7., , , .
- 15Reproductive factors and pancreatic cancer risk: a Norwegian cohort study. Br J Cancer 2008; 98: 189–93., , , .
- 16Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai. China. Int J Cancer 1996; 66: 432–7., , , , , , , .
- 17Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control 1993; 4: 375–82., , , , , .
- 18Parity and the risk of pancreatic cancer: a nested case-control study. Int J Cancer 1998; 77: 224–7., , , , .
- 19Hormonal factors and pancreatic cancer in women. Ann Epidemiol 2001; 11: 563–7., , .
- 20Parity in relation to mortality and cancer incidence: a prospective study of Norwegian women. Int J Epidemiol 1994; 23: 691–9., , .
- 21Long-term impact of reproductive factors on cancer risk. Int J Cancer 1993; 53: 215–9., , , .
- 22A multifactorial model for pancreatic cancer in man. Epidemiologic evidence. JAMA 1981; 245: 147–52., .
- 23Association of menstrual and reproductive factors with pancreatic cancer risk in women: findings of the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. J Gastroenterol 2006; 41: 878–83., , , , , , , , , .
- 24Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk. Pancreas 2007; 35: 120–9., , , , , , , , , .
- 25Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 1986; 76: 49–60., , , .
- 26Hormonal and reproductive factors and pancreatic cancer risk: a prospective cohort study. Pancreas 2005; 30: 369–74., , .
- 27Pancreatic cancer incidence in relation to female reproductive factors: Iowa Women's Health Study. JOP 2007; 8: 16–27., , , .
- 28Parity, reproductive factors, and the risk of pancreatic cancer in women. Cancer Epidemiol Biomarkers Prev 2003; 12: 433–8., , , , , , .
- 29Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of U.S. women (United States). Cancer Causes Control 2005; 16: 1035–40., , , , .
- 30A case control study of cancer of the pancreas. Cancer 1973; 31: 641–8., , , .
- 31CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors: a HuGE review. Am J Epidemiol 2004; 160: 729–40., , , .
- 32Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994; 3: 1873–6., , , , , , , .
- 33CYP17 and breast cancer risk: the polymorphism in the 5′ flanking area of the gene does not influence binding to Sp-1. Cancer Res 1999; 59: 2825–8., , , , , , , .
- 34Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Am J Epidemiol 2007; 165: 235–45., , .
- 35Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res 1998; 58: 585–7., , , , , .
- 36CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 2007; 16: 2237–46., , , , , , , , , , , , et al.
- 37Association of CYP17. CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2004; 13: 94–101., , , , , , , , , , , .
- 38Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project. Carcinogenesis 2008; 29: 766–71., , , , , , , , , , , .
- 39A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 1997; 57: 1063–5., , , , .
- 40Concerning the CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis 2002; 17: 445–6., , .
- 41Genetic variation in CYP17 and endometrial cancer risk. Hum Genet 2008; 123: 155–62., , , , , , .
- 42Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2003; 12: 120–6., , .
- 43Genetic polymorphisms in CYP17. CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in. African-American men: the Flint Men's Health Study. Prostate 2008; 68: 296–305., , , , , , .
- 44Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev 2005; 14: 2093–7., , .
- 45Whole grains and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. California. Am J Epidemiol 2007; 166: 1174–85., , .
- 46Pancreatic cancer, animal protein and dietary fat in a population-based study: San Francisco Bay Area California. Cancer Causes Control 2007; 18: 1153–67., , .
- 47Anthropometric factors and pancreatic cancer in a population-based case-control study in the San Francisco Bay area. Cancer Causes Control 2005; 16: 1235–44., , .
- 48Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol 2003; 158: 432–41., , .
- 49Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area. California. Cancer Epidemiol Biomarkers Prev 2006; 15: 1458–63., , .
- 50A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J Natl Cancer Inst 2002; 94: 297–306., , , , , .
- 51Inflammation, genetic polymorphisms in proinflammatory genes TNF-A. RANTES, and CCR5, and risk of pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 726–31., , , , .
- 52Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 1470–9., , , , , .
- 53A population-based study of the Arg399Gln polymorphism in X-Ray Repair Cross-Complementing Group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res 2002; 62: 4630–6., , , , .
- 54CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women. Mol Hum Reprod 2007; 13: 231–6., , , , .
- 55CYP17 genotypes differ in salivary 17-beta estradiol levels: a study based on hormonal profiles from entire menstrual cycles. Cancer Epidemiol Biomarkers Prev 2006; 15: 2131–5., , , , , , .
- 56Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004; 96: 434–42., , , , .
- 57HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore. Int J Cancer 2003; 104: 450–7., , , , , .
- 58Systematic replication study of reported genetic associations in prostate cancer: strong support for genetic variation in the androgen pathway. Prostate 2006; 66: 1729–43., , , , , , , , , , , , et al.
- 59Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Cancer Res 2006; 66: 4309–18., , , , .